Rodríguez Feria Daniela, Diaz Brochero Cándida Rosa, Muñoz Velandia Oscar, Verhelst López José Manuel, Garzón Herazo Javier Ricardo
School of Medicine, Department of Internal Medicine, Pontificia Universidad Javeriana. Hospital Universitario San Ignacio, Bogotá, Colombia.
School of Medicine, Department of Internal Medicine, Pontificia Universidad Javeriana. Hospital Universitario San Ignacio, Bogotá, Colombia; Infectious Diseases Unit, Hospital Universitario San Ignacio, Bogotá, Colombia; School of Medicine, Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogotá, Colombia.
Infect Dis Now. 2025 Aug;55(5):105080. doi: 10.1016/j.idnow.2025.105080. Epub 2025 May 2.
Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with increased mortality and higher healthcare costs in hospitalized patients, making it reasonable to explore the effectiveness of strategies for decolonization of intestinal carriage.
To evaluate the effectiveness and safety of oral and/or intravenous antibiotics in adults colonized by CRE.
We conducted a systematic review of randomized clinical trials and nonrandomized studies comparing oral and/or intravenous antibiotic therapy versus no treatment or placebo in adults colonized by CRE. Outcomes assessed included eradication, infection rate, mortality, length of hospital stay, and adverse events. Searches were performed in the Embase, MEDLINE (PubMed), and Cochrane Library. Quality assessment was conducted using the ROB1 or ROBINS-I tool. Meta-analysis was performed using a random effects model in Review Manager, and the certainty of evidence was evaluated using the GRADE methodology.
Seven studies comprising 728 participants were included. Decolonization therapy was significantly associated with intestinal carriage eradication (OR: 2.66; 95% CI: 1.55-4.55; I: 0%). There was a trend toward a reduced infection rate (OR: 0.66; 95% CI: 0.26-1.65; I: 4%). Data on mortality and adverse events were limited and insufficient to draw conclusions about differences between groups. The certainty of evidence ranged from moderate to very low.
This study suggests that decolonization therapy may be effective in eradicating CRE intestinal carriage state, but current evidence is insufficient to determine its impact on infection rates, mortality, or adverse events. Larger, high-quality randomized clinical trials are necessary to generate robust evidence supporting its clinical use.
耐碳青霉烯类肠杆菌科细菌(CRE)感染与住院患者死亡率增加及医疗成本升高相关,因此探索肠道定植菌去定植策略的有效性是合理的。
评估口服和/或静脉用抗生素对CRE定植成人患者的有效性和安全性。
我们对随机临床试验和非随机研究进行了系统评价,比较口服和/或静脉用抗生素治疗与不治疗或安慰剂对CRE定植成人患者的效果。评估的结局包括根除率、感染率、死亡率、住院时间和不良事件。检索了Embase、MEDLINE(PubMed)和Cochrane图书馆。使用ROB1或ROBINS-I工具进行质量评估。在Review Manager中使用随机效应模型进行荟萃分析,并使用GRADE方法评估证据的确定性。
纳入了7项研究,共728名参与者。去定植治疗与肠道定植菌根除显著相关(OR:2.66;95%CI:1.55 - 4.55;I²:0%)。感染率有降低趋势(OR:0.66;95%CI:0.26 - 1.65;I²:4%)。关于死亡率和不良事件的数据有限,不足以得出组间差异的结论。证据的确定性从中度到极低不等。
本研究表明,去定植治疗可能有效根除CRE肠道定植状态,但目前的证据不足以确定其对感染率、死亡率或不良事件的影响。需要开展更大规模、高质量的随机临床试验,以产生有力证据支持其临床应用。